Phio Pharmaceuticals Corp. Cash And Cash Equivalents At Carrying Value

Quick Answer

Phio Pharmaceuticals Corp. reported Cash And Cash Equivalents At Carrying Value of $21.03 million for the year ending 2025.

  • Phio Pharmaceuticals Corp. showed an increase of +290.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Phio Pharmaceuticals Corp.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2011 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2011 to 2025), Phio Pharmaceuticals Corp.'s Cash And Cash Equivalents At Carrying Value has grown by 4,081.1%.
  • Historical annual values: Fiscal year 2025: $21.03 million | Fiscal year 2024: $5.38 million | Fiscal year 2023: $8.49 million | Fiscal year 2017: $3.58 million | Fiscal year 2016: $12.91 million | Fiscal year 2015: $5.12 million | Fiscal year 2014: $8.50 million | Fiscal year 2013: $11.39 million | Fiscal year 2012: $5.13 million | Fiscal year 2011: $503.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: